Repurposing existing drugs for new uses: a cohort study of the frequency of FDA-granted new indication exclusivities since 1997
Background Drug repurposing (i.e., finding novel uses for existing drugs) is essential for maximizing medicines' therapeutic utility, but obtaining regulatory approval for new indications is costly. Policymakers have therefore created temporary indication-specific market exclusivities to incent...
Saved in:
Main Authors: | Babak Sahragardjoonegani (Author), Reed F. Beall (Author), Aaron S. Kesselheim (Author), Aidan Hollis (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mapping the existing body of knowledge on new and repurposed TB vaccine implementation: A scoping review.
by: Joeri S Buis, et al.
Published: (2024) -
Mapping the existing body of knowledge on new and repurposed TB vaccine implementation: A scoping review
by: Joeri S. Buis, et al.
Published: (2024) -
Granting Exclusive Breastfeeding Certificate to Increase Maternal Motivation for Exclusive Breastfeeding
by: Dian Nurafifah, et al.
Published: (2022) - First polio case in southern Africa since 1997
-
The timing of 30‐month stay expirations and generic entry: A cohort study of first generics, 2013-2020
by: Sunand Kannappan, et al.
Published: (2021)